Skip to main content
OpenTrials
Completed

NCT Number: NCT03729583

The Effects of Breathing Retraining in Patients With Interstitial Lung Diseases

Breathing retraining has been reported to lead to improvements in dyspnoea and walking distance in chronic obstructive pulmonary disease (COPD) patients. Evidence regarding the effects of such an intervention in ILD patients is though lacking. In view of this, the aims of such a study were to identify whether breathing retraining led to better management of dyspnoea and improved walking distance in ILD patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Interstitial Lung Disease Lung Diseases Lung Diseases, Interstitial Respiratory Tract Diseases

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Melanie Axiak

Mosta, Malta

About this study

One of the commonest symptoms experienced in patients with a diagnosis of interstitial lung disease (ILD) is shortness of breath, a symptom which greatly affects their abilities to carry out activities of daily living. Breathing retraining has been reported to lead to improvements in dyspnoea and walking distance in chronic obstructive pulmonary disease (COPD) patients. Evidence regarding the effects of such an intervention in ILD patients is though lacking. In view of this, the aims of such a study were to identify whether breathing retraining led to better management of dyspnoea and improved walking distance in ILD patients. Twenty Seven ILD patients were randomly distributed to either the control group (n=15) which received a 12-week Pulmonary Rehabilitation (PR) programme without breathing retraining or the active group (n=12) which received a 12-week PR programme with breathing retraining. All patients had both the 6-minute walk test and their level of breathlessness assessed using the Dyspnoea Borg scale assessed at baseline and at 4 weekly intervals for a 12-week period throughout the programme.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with a confirmed diagnosis of ILD and who were referred for PR

Exclusion criteria

  • Patients who had musculoskeletal or neurological conditions affecting the outcome measures
  • Patients who required oxygen therapy and did not accept administration
  • Patients with unstable cardiovascular conditions
  • Patients who were not willing to participate

Treatment and study plan

Pulmonary rehabilitation

Behavioral

A 12 week high intensity PR programme was delivered to both groups. The active group had additional breathing control interventions and exercises

Other names: Respiratory Rehabilitation

Primary outcomes

  1. 6 minute walk test

    Time frame: Change in walking distance from baseline to 12weeks

    A walk test to examine exercise endurance

Secondary outcomes

  1. Dyspnoea score

    Time frame: Change in dyspnoea measures from baseline to 12weeks

    Borg scale

Sponsors and collaborators

Lead sponsor

University of Malta

Other

Registry information

Official study title

The Effects of Breathing Retraining on Dyspnoea Measures and the Six-Minute Walking Distance in Patients With Interstitial Lung Diseases

Important dates

Study start
2017
Primary completion
2017
Study completion
2018
First posted
Nov 2, 2018
Registry last updated
Nov 2, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.